Gudimetla K. An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia. AJP [Internet]. 2023 Jun. 15 [cited 2024 May 20];17(2). Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/4859